1 ertapenem versus piperacillin/tazobactam for foot infections.

2 IL-8 was seen in 8 of 8 patients with active foot infection and diffuse uptake was seen in the thumb

3 enously into 8 diabetic patients with active foot infections and evidence of osteomyelitis, 2 patient

4                                              Foot infections are a common and serious problem in pers

5                                     Diabetic foot infections are a common and serious problem, yet fe

6                                     Diabetic foot infections are a leading cause of lower extremity a

7                                     Diabetic foot infections cause substantial morbidity and mortalit

8  trial in adults (n=586) with diabetes and a foot infection classified as moderate-to-severe and requ

9                                     Diabetic foot infections (DFIs) typically begin in a wound, most

10 the treatment of moderate-to-severe diabetic foot infections (DFIs), we obtained 454 pretreatment spe

11 associated with improved clinical outcome of foot infection in diabetic patients.

12 adjuvant therapy for the treatment of severe foot infections in diabetic patients.

13  absent from invasive isolates from diabetic foot infections, including osteomyelitis.

14 the most common infection in the first year, foot infections predominated thereafter.

15                    40 diabetic patients with foot infections were enrolled in a double-blind placebo-

16 onsidered for parenteral therapy of diabetic foot infections, when deemed appropriate.